11-19185023-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PM2PP3_Moderate
The NM_003476.5(CSRP3):c.437G>A(p.Arg146His) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000242 in 1,614,156 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_003476.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 4 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152236Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000199 AC: 5AN: 251390Hom.: 0 AF XY: 0.00000736 AC XY: 1AN XY: 135860
GnomAD4 exome AF: 0.0000239 AC: 35AN: 1461802Hom.: 0 Cov.: 31 AF XY: 0.0000261 AC XY: 19AN XY: 727216
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152354Hom.: 0 Cov.: 33 AF XY: 0.0000268 AC XY: 2AN XY: 74506
ClinVar
Submissions by phenotype
not provided Uncertain:3
- -
- -
- -
Dilated cardiomyopathy 1M;C2677491:Hypertrophic cardiomyopathy 12 Uncertain:2
This sequence change replaces arginine, which is basic and polar, with histidine, which is basic and polar, at codon 146 of the CSRP3 protein (p.Arg146His). This variant is present in population databases (rs377066670, gnomAD 0.01%). This missense change has been observed in individual(s) with hypertrophic cardiomyopathy (PMID: 28790153). ClinVar contains an entry for this variant (Variation ID: 163009). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
- -
not specified Uncertain:1
The Arg146His variant in CSRP3 has not been previously reported in individuals w ith cardiomyopathy, but has been identified in 1/8586 European American chromoso mes by the NHLBI Exome Sequencing Project (http://evs.gs.washington.edu/EVS). Co mputational prediction tools and conservation analysis suggest that the Arg146Hi s variant may impact the protein, though this information is not predictive enou gh to determine pathogenicity. Additional information is needed to fully assess the clinical significance of the Arg146His variant. -
Prolonged QT interval Uncertain:1
- -
Cardiomyopathy Uncertain:1
- -
Hypertrophic cardiomyopathy Uncertain:1
The CSRP3 Arg146His variant is present in the Genome Aggregation Database (http://gnomad.broadinstitute.org/) at an allele frequency of 0.00002. We have identified this variant in 1 HCM proband who has no family history of disease or SCD. Interestingly, a different rare variant at this position (Arg146Cys) has been reported in cardiomyopathy patients. Computational tools SIFT, MutationTaster, and PolyPhen-2 predict this variant to have a deleterious effect. Although there is evidence to suggest that CSRP3 variants are associated with HCM (Geier C. et al., 2008), further investigation is required to fully understand the role of CSRP3 Arg146His in disease pathogenesis. Hence, we classify CSRP3 Arg146His as a variant of "uncertain significance". -
Cardiovascular phenotype Uncertain:1
The p.R146H variant (also known as c.437G>A), located in coding exon 4 of the CSRP3 gene, results from a G to A substitution at nucleotide position 437. The arginine at codon 146 is replaced by histidine, an amino acid with highly similar properties. This alteration has been reported in cardiomyopathy cohorts; however, clinical details were limited (Robyns T et al. Eur J Hum Genet, 2017 Dec;25:1313-1323; Burns C et al. Circ Cardiovasc Genet, 2017 Aug;10:[ePub ahead of print]; van Lint FHM et al. Neth Heart J, 2019 Jun;27:304-309). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at